As Nvidia reports, here’s the history of what happens next after ten giant stocks outperform
The fund manager AllianceBernstein looked at periods where the top 10 stocks dominated over the last three decades.
Stock Market Today: Dow ends lower for 4th straight day, Nasdaq pops 1% as Wall Street shakes off Russia's nuclear shift
This Fed-based market signal is flashing a warning for the first time in over a decade. Here’s why it matters.
Ex-Nomura staffer charged after attempted murder at elderly client’s home
A former Nomura employee has been charged with robbery, attempted murder, and arson of an inhabited building following an ...
Nvidia earnings: Stock near highs as AI fever faces its next big test
Nvidia is due to report fiscal third-quarter earnings after Wednesday's closing bell. MarketWatch will be breaking down the ...
‘I’ve accumulated a nice retirement fund and my house is paid off’: How do I ensure my son-in-law never gets his hands on my money?
I am a divorced woman in my 70s. I have accumulated a nice retirement fund and my house is paid off. I will definitely be ...
Here’s your $22 million chance to be neighbors with Bill Gates or Jeff Bezos, and why billionaires love this town so much
A staggering waterfront “smart home” that is located in a billionaire-loved Seattle suburb has been put on the market for $22 ...
U.S. Embassy in Kyiv shuts due to Russian air attack threat after Biden policy shift
The U.S. Embassy in Kyiv said it would stay closed Wednesday after receiving a warning of a potentially significant Russian ...
Hedge funds have already started bailing out of ‘Trump trades’
Hedge funds switched to become net sellers of financial and industrial stocks having previously piled into the two sectors in ...
Pfizer Gets European Approval of Hympavzi Hemophilia Drug
Pfizer said the green light makes Hympavzi the first once-weekly subcutaneous treatment in the European Union for people with severe hemophilia B and the first to be administered via a pre-filled pen ...
Target’s stock plunges toward a one-year low after a triple-miss earnings report and downbeat outlook
Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore. Back To Top ...
Sage Therapeutics’ stock slides after trial of Huntington’s Disease treatment fails and company says it will end it
Sage Therapeutics Inc.’s stock SAGE fell 18% early Wednesday, after the company said a mid-stage trial of a treatment for cognitive impairment associated with Huntington’s Disease failed to meet its ...
Pfizer names oncology chief Chris Boshoff as new chief scientific officer
Pfizer Inc. PFE named oncology chief Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1. The drug company had been searching for a new chief ...